Hemostasis
Title
Date Published
Hemostatic agents: which is better?
December 1, 2010
Use of recombinant factor VIIa for the prevention and treatment of bleeding in patients without hemophilia: a systematic review and meta-analysis.
November 15, 2010
The use of recombinant erythropoietin for the treatment of chemotherapy-induced anemia in patients with ovarian cancer does not effect progression-free or overall survival.
November 8, 2010
Implementing methods to improve perioperative hemostasis in the surgical and trauma settings.
October 15, 2010
Platelet gel for the treatment of traumatic loss of finger substance.
October 1, 2010
Effects of fibrinogen concentrate administration during severe hemorrhage.
October 1, 2010
Recombinant activated factor VII for postoperative hemorrhage following repair of acute type A aortic dissection.
October 1, 2010
Use of recombinant activated factor VII for reduction of perioperative blood loss during elective surgical correction of spine deformity in a Jehovah’s Witness. Case report.
September 30, 2010
Re-evaluation of the role of antifibrinolytic therapy with lysine analogs during cardiac surgery in the post aprotinin era.
September 24, 2010
Tranexamic acid: an alternative to aprotinin as antifibrinolytic therapy in pediatric congenital heart surgery.
September 15, 2010
Results of the CONTROL trial: efficacy and safety of recombinant activated Factor VII in the management of refractory traumatic hemorrhage.
September 1, 2010
Minimally invasive management of postoperative bleeding after radical prostatectomy: transarterial embolization.
September 1, 2010
Mortality associated with administration of high-dose tranexamic acid and aprotinin in primary open-heart procedures: a retrospective analysis.
August 3, 2010
Fibrinolytic therapy and bleeding complications: risk predictors from RIKS-HIA.
July 23, 2010
Evidence supporting the use of recombinant activated factor VII in congenital bleeding disorders.
July 21, 2010
Recombinant factor VIII concentrates.
July 14, 2010
Recombinant activated factor VII: mechanisms of action and current indications.
July 14, 2010
Management of major blood loss: an update.
July 6, 2010
Total hepatectomy, recombinant activated factor VII and rescue liver transplantation.
July 1, 2010
Prolonged prothrombin time after recombinant activated factor VII therapy in critically bleeding trauma patients is associated with adverse outcomes.
July 1, 2010